Meta-analysis and systematic review: The administration of glucocorticoids, as a line of treatment for COVID-19 patients, could result in lowering mortality
The aim of this meta-analysis was to investigate the association between the use of glucocorticoids and the mortality of covid-19 patients. Trials were identified through a comprehensive systematic search of four medical databases including PubMed, Cochrane Library, Web of Science, and Embase. We al...
Saved in:
Main Authors: | Zhou Enhao (Author), Li You (Author), Hu Danlan (Author), Dai Yuchi (Author), Wang Tian (Author), Yang Chun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoporosis as a result of the long-term administration of glucocorticoids in patients suffering from acantholytic pemphigus
by: M. A. Ufimtseva, et al.
Published: (2017) -
Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis
by: Ying Chi, et al.
Published: (2021) -
Ganoderma lucidum Immune Modulator Protein rLZ-8 Could Prevent and Reverse Bone Loss in Glucocorticoids-Induced Osteoporosis Rat Model
by: Yong Yang, et al.
Published: (2020) -
Effect of p16 on glucocorticoid response in a B-cell lymphoblast cell line
by: Sun-Young Kim, et al.
Published: (2010) -
Pharmacological inhibition of lipolysis prevents adverse metabolic outcomes during glucocorticoid administration
by: Melissa A. Linden, et al.
Published: (2023)